Inactief instrument

Andere talen ASLAN Pharmaceuticals Limited Taipei Exchange

Aandelen

6497

KYG054241099

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading	16:40
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	15/05
Asian Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	14/05
Asian Equities Traded in the US as American Depositary Receipts Begin Week Higher	13/05
ASLAN Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05
Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading	08/05
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading	07/05
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event	07/05
Aslan Pharmaceuticals to Present Additional Data from Interim Analysis of Trek-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event	07/05
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Monday Trading	06/05
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher	03/05
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	02/05
ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics	02/05
ASLAN Pharmaceuticals Announces Expansion of its Collaboration with Zenyaku Kogyo Co., Ltd. to Investigate Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics	02/05
Asian Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	01/05
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab	30/04
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note in Monday Trading	29/04
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%	26/04
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	25/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ASLAN Pharmaceuticals Limited Taipei Exchange

Aandelen

6497

KYG054241099

Andere talen

Filters